hyperpigmentation. Other melanin hyperpigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Skin Type (III -IV) Aged between 18 to 60 years Signed informed consent voluntarily and knowingly
Exclusion criteria
Exclusion criteria: Use any light sensitive drug within 3 months prior to the study Active skin disease at test area: rosacea, atrophy, acne, eczema Use of topical lightening products like AHA ,BHA and retinoid components within 21 days prior to the study Documented allergies to components of test product Use of contraceptive or any hormonal drugs History of laser treatment or dermabrasion or deep facial peels within the past 3 months difficulty swallowing (a condition that could impact digestion and/or absorption) Active smoker ( last 1 years) Current pregnancy/ breast feeding Systemic disease (diabetics, hepatic disease, uncontrolled hypothyroidism)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The numbers of skin spots, its size and percentage. Timepoint: At the beginning and after 8 weeks. Method of measurement: Visioface device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences